Course details
Cedars Sinai Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI 38th Annual Case Review with the Experts 2026
YOU WILL GET THE COURSE VIA LIFETIME DOWNLOAD LINK (FAST SPEED) AFTER PAYMENT
Friday, January 23, 2026, 7:30 AM – Sunday, January 25, 2026, 2:55 PM PT, Cedars-Sinai Harvey Morse Conference Center, Los Angeles, CA
Professions – Nurse, Nurse (Advanced Practice NP CRNA CNM CNS), Physician, Physician Assistant, Radiologic Technologist, Researcher (non-physician), Researcher (physician), Technician
A major national healthcare imperative for noninvasive imaging is for the tests to provide value. Nuclear cardiology and cardiac CT studies provide powerful tools for diagnosis, risk assessment, and guiding management of selected patients with known or suspected cardiac disease. In the current environment, imaging must address the combined considerations of improving outcomes and containing costs. To this end, advanced cardiac imaging studies must be ordered on the right patients and optimally performed, interpreted, reported, and acted upon by physicians and allied health professionals. Additionally, effective methods to reduce radiation exposure need to be implemented to maximize patient safety. There is a clear need for physicians ordering, performing and interpreting the tests to understand the issues regarding value-based imaging and to optimally implement this understanding. We meet these educational needs through a live activity entitled: Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI: 38th Annual Case Review with the Experts. The course is designed to meet the current needs of professionals who perform or request nuclear cardiology or cardiac CT. The course covers the use of these modalities across the spectrum of patients routinely seen by cardiologists in typical day-to-day practice and is designed to improve ordering patterns and increase quality in performing, interpreting, reporting and applying the advanced imaging methods. A unique feature of the program is the extensive use case presentations of each subject as a proven effective teaching tool. It also includes multiple sessions with group faculty discussions. There is a focus on incorporating new guidelines in practice and the latest evidence from clinical trials and registry findings
AI in Cardiac CTA- Quantification of Coronary Plaque- Prediction of Risk-Prediction, and Ischemia
Amyloid Quantitation- Decreasing Subjectivity in PYP Interpretation
Amyloid Specific PET Tracers
Beyond Perfusion with MPI- AI Analysis of CAC, Chamber Volumes, Epicardial Fat, Body Composition and Beyond
Beyond the Images- The Essential Role of Excercise and Functional Assessment in Cardiac Testing
Cardiac MRI and PET in Microvascular Disease
Cardiac MRI in Sarcoidosis and Other Inflammatory Cardiomyopathies
Case Review- CTA in Valvular Disease
Case-Based Interpretation of Flurpiridaz MPI
Central Role of Cardiac CT in Structural Heart Disease
Changing the Outlook in Cardiac Amyloidosis- Current and Novel Therapies
Choosing Between Flurpiridaz and Rubidium
Class IA Guideline Recommendation for Chest Pain- What Evidence Brought Coronary CTA Here
Clinical Value of Myocardial Blood Flow Measurement
Combining Anatomy and Physiology with SPECT and PET. Crucial Role of CAC Scanning in Patients
Coronary Artery Calcium (CAC) Scanning- Central Role in Preventive Cardiology
Coronary CT in Mitral Valve and Afib- Watchman and TMVR
Coronary CTA and FFRct for the Interventionalist- Use in Planning and Guiding PCI
Coronary CTA in Asymptomatic Patients
Coronary CTA in Evaluation of Patients with Known CAD (Stents, CABG)
Coronary CTA in Evaluation of Suspected CAD in Daily Practice
Coronary CTA- Special Consideration for Women
Debate- Coronary CTA Will Replace Stress Testing
Evolving Trends in CAD- Shifting Risk Factors, Symptoms, and Mortality Drivers
FDG PET in Sarcoidosis- Practical Considerations
Flurpiridaz- The Ideal PET Perfusion Tracer
Game-Show Jeopardy- Cardiac CT, Nuclear, and CMR
How to Integrate Stress Myocardial Blood Flow and Flow Reserve in Clinical Reporting and Guiding Therapy
How to Start Using Flurpiridaz- Lab Preparation, Protocols, Exercise vs Pharmacologic Stress
Incorporating Artificial Intelligence in Interpreting Reports of SPECT MPI- Case Interpretations
Integrating Visual and Quantitative Analyses of SPECT and PET- Improving Your Scan Interpretation- Case Illustrations
Ischeia Evaluation with Coronary CTA- FFRct
MBF-MFR with Cardiac MRI- Becoming Routine in Stress MRI
MBF-MFR with PET- How to Perform Quality Control, Interpret and Report
MFR with SPECT- Ready for Prime Time-
MRI in Cardiac Amyloidosis- Strengths and Limitations
My Best Teaching Cases
Myocardial Bridging and Coronary Anomalies on Coronary CTA- When is Further Assessement Needed and What Should It Be
Myocardial Viability- CMR and FDG PET
Nuclear Cardiology in 2026 and Beyond
Perfusion and Blood Flow Quantitation- Transmural and Subendocardial
PET or SPECT- Right Test for the Right Patient
Pharmacologic Stress- Combined with Exercise or Alone- What You Need to Know
Plaque Imaging in Guiding Patient Management
Problems fo Coronary CTA- Small Stents, CAC, Breathing
Putting it All Together- Value-Based Use of Cardiac Imaging
Quantitation in Sarcoidosis Interpretation
Quantitative Plaque Analysis in Tracking Progression of Disease
Stress First SPECT Protocols- Improved Defect Detection, Stress Only Procedures
Tc-99m Pyrophosphate (PYP) Imaging- Acquisition, Processing, Interpretation PET-based Radiotracers
The Disease, the Suspicion-Diagnostic Pathways, and Treatments
The Future of Cardiac CT- Photon Counting CT and More
